159 related articles for article (PubMed ID: 31994797)
1. Anti-inflammatory and metabolic reprogramming effects of MENK produce antitumor response in CT26 tumor-bearing mice.
Tuo Y; Zhang Z; Tian C; Hu Q; Xie R; Yang J; Zhou H; Lu L; Xiang M
J Leukoc Biol; 2020 Jul; 108(1):215-228. PubMed ID: 31994797
[TBL] [Abstract][Full Text] [Related]
2. Novel modulation on myeloid-derived suppressor cells (MDSCs) by methionine encephalin (MENK).
Geng J; Yuan Y; Jiao X; Wang R; Liu N; Chen H; Griffin N; Shan F
Int Immunopharmacol; 2019 Mar; 68():193-203. PubMed ID: 30654309
[TBL] [Abstract][Full Text] [Related]
3. Methionine enkephalin (MENK) inhibits human gastric cancer through regulating tumor associated macrophages (TAMs) and PI3K/AKT/mTOR signaling pathway inside cancer cells.
Wang X; Jiao X; Meng Y; Chen H; Griffin N; Gao X; Shan F
Int Immunopharmacol; 2018 Dec; 65():312-322. PubMed ID: 30343258
[TBL] [Abstract][Full Text] [Related]
4. Methionine enkephalin (MENK) mounts antitumor effect via regulating dendritic cells (DCs).
Meng Y; Gao X; Chen W; Plotnikoff NP; Griffin N; Zhang G; Shan F
Int Immunopharmacol; 2017 Mar; 44():61-71. PubMed ID: 28088065
[TBL] [Abstract][Full Text] [Related]
5. Regulatory role of methionine enkephalin in myeloid-derived suppressor cells and macrophages in human cutaneous squamous cell carcinoma.
Bai X; Shan F; Qu N; Huang H; Handley M; Griffin N; Zhang S; Cao X
Int Immunopharmacol; 2021 Oct; 99():107996. PubMed ID: 34311187
[TBL] [Abstract][Full Text] [Related]
6. CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver.
Kuniyasu H; Luo Y; Fujii K; Sasahira T; Moriwaka Y; Tatsumoto N; Sasaki T; Yamashita Y; Ohmori H
Gut; 2010 Mar; 59(3):348-56. PubMed ID: 19828468
[TBL] [Abstract][Full Text] [Related]
7. Induction on differentiation and modulation of bone marrow progenitor of dendritic cell by methionine enkephalin (MENK).
Liu J; Chen W; Meng J; Lu C; Wang E; Shan F
Cancer Immunol Immunother; 2012 Oct; 61(10):1699-711. PubMed ID: 22392190
[TBL] [Abstract][Full Text] [Related]
8. The paradoxical role of methionine enkephalin in tumor responses.
Tuo Y; Tian C; Lu L; Xiang M
Eur J Pharmacol; 2020 Sep; 882():173253. PubMed ID: 32535097
[TBL] [Abstract][Full Text] [Related]
9. Methionine enkephalin inhibits colorectal cancer by remodeling the immune status of the tumor microenvironment.
Wang X; Li S; Yan S; Shan Y; Wang X; Jingbo Z; Wang Y; Shan F; Griffin N; Sun X
Int Immunopharmacol; 2022 Oct; 111():109125. PubMed ID: 35988519
[TBL] [Abstract][Full Text] [Related]
10. Brevilin A induces apoptosis and autophagy of colon adenocarcinoma cell CT26 via mitochondrial pathway and PI3K/AKT/mTOR inactivation.
You P; Wu H; Deng M; Peng J; Li F; Yang Y
Biomed Pharmacother; 2018 Feb; 98():619-625. PubMed ID: 29289836
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of cancer via mediation of cytotoxic T lymphocytes by methionine enkephalin (MENK).
Li W; Chen W; Herberman RB; Plotnikoff NP; Youkilis G; Griffin N; Wang E; Lu C; Shan F
Cancer Lett; 2014 Mar; 344(2):212-22. PubMed ID: 24291668
[TBL] [Abstract][Full Text] [Related]
12. Methionine enkephalin suppresses lung cancer metastasis by regulating the polarization of tumor-associated macrophages and the distribution of myeloid-derived suppressor cells in the tumor microenvironment and inhibiting epithelial-mesenchymal transition.
Zhang S; Geng J; Shan F; Shan Y; Griffin N; Wu B; Wang X
Int Immunopharmacol; 2023 May; 118():110064. PubMed ID: 36989897
[TBL] [Abstract][Full Text] [Related]
13. mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors.
Wu T; Zhao Y; Wang H; Li Y; Shao L; Wang R; Lu J; Yang Z; Wang J; Zhao Y
Sci Rep; 2016 Feb; 6():20250. PubMed ID: 26833095
[TBL] [Abstract][Full Text] [Related]
14. Gansui-Banxia Decoction extraction inhibits MDSCs accumulation via AKT /STAT3/ERK signaling pathways to regulate antitumor immunity in C57bl/6 mice.
Feng XY; Chen BC; Li JC; Li JM; Li HM; Chen XQ; Liu D; Li RT
Phytomedicine; 2021 Dec; 93():153779. PubMed ID: 34638030
[TBL] [Abstract][Full Text] [Related]
15. A novel mechanism of lung cancer inhibition by methionine enkephalin through remodeling the immune status of the tumor microenvironment.
Zhang S; Huang H; Handley M; Griffin N; Bai X; Shan F
Int Immunopharmacol; 2021 Oct; 99():107999. PubMed ID: 34315116
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo killing effects of methionine enkephalin on osteosarcoma.
Huang H; Wang X; Zhang S; Bai X; Griffin N; Shan Y; Shan F
Int Immunopharmacol; 2023 Dec; 125(Pt B):111226. PubMed ID: 37976597
[TBL] [Abstract][Full Text] [Related]
17. Immunogenic chemotherapy in two mouse colon cancer models.
Taniura T; Iida Y; Kotani H; Ishitobi K; Tajima Y; Harada M
Cancer Sci; 2020 Oct; 111(10):3527-3539. PubMed ID: 32816355
[TBL] [Abstract][Full Text] [Related]
18. Oxymatrine synergistically enhances antitumor activity of oxaliplatin in colon carcinoma through PI3K/AKT/mTOR pathway.
Liu Y; Bi T; Wang Z; Wu G; Qian L; Gao Q; Shen G
Apoptosis; 2016 Dec; 21(12):1398-1407. PubMed ID: 27671687
[TBL] [Abstract][Full Text] [Related]
19. Juglone eliminates MDSCs accumulation and enhances antitumor immunity.
Wang H; Zou C; Zhao W; Yu Y; Cui Y; Zhang H; E F; Qiu Z; Zou C; Gao X
Int Immunopharmacol; 2019 Aug; 73():118-127. PubMed ID: 31085459
[TBL] [Abstract][Full Text] [Related]
20. Methionine enkephalin inhibited cervical carcinoma via apoptosis promotion and reduction of myeloid derived suppressor cell infiltrated in tumor.
Qu N; Wang R; Meng Y; Liu N; Zhai J; Shan F
Int Immunopharmacol; 2022 Sep; 110():108933. PubMed ID: 35738090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
